<doc>
  <docmeta id="113s2645is">
    <bill congress="113" type="s" number="2645" version="is"/>
    <revision size="15796" annotations="0" status="complete" id="4" commit-time="2014-07-31T22:39:22Z" committer="mbohmer" doc="113s2645is/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2645 IS: TREAT Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-07-23</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
    <session>2d Session</session>
		<legis-num>S. 2645</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140723">July 23, 2014</action-date>
			<action-desc>
        <sponsor name-id="S369">Mr. Markey</sponsor> (for himself, <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>, <cosponsor name-id="S176">Mr. Rockefeller</cosponsor>, <cosponsor name-id="S307">Mr. Brown</cosponsor>, <cosponsor name-id="S361">Ms. Hirono</cosponsor>, and <cosponsor name-id="S253">Mr. Durbin</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To provide access to medication-assisted therapy, and for other purposes.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
		  <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <quote>
          <short-title>
              <cato:entity-ref entity-type="act" value="Recovery Enhancement for Addiction Treatment Act" proposed="true">Recovery Enhancement for Addiction Treatment Act</cato:entity-ref>
            </short-title>
        </quote> or the <quote>
            <cato:entity-ref entity-type="act" value="TREAT Act" proposed="true">TREAT Act</cato:entity-ref>
          </quote>
        </cato:entity>.</text>
    </section>
    <section id="id2f389d28114840cea82c9a68aec6e2ee">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">Congress finds the following:</text>
      <paragraph id="id59e8149eee5c4ea7a9955fba964201f2">
        <enum>(1)</enum>
        <text>Overdoses from opioids have increased dramatically in the United States.</text>
      </paragraph>
      <paragraph id="id62042d8e55014162b67c973dd4e4a0be">
        <enum>(2)</enum>
        <text>Deaths from drug overdose, largely from prescription pain relievers, have tripled among men and
			 increased five-fold among women over the past decade.</text>
      </paragraph>
      <paragraph id="id3499fbe223f3458b8972a07d97d77a72">
        <enum>(3)</enum>
        <text>Nationwide, drug overdoses now claim more lives than car accidents.</text>
      </paragraph>
      <paragraph id="idfc80d4b2020a4346b19230bc6be311ab">
        <enum>(4)</enum>
        <text>Opioid addiction is a chronic disease that, untreated, places a large burden on the healthcare
			 system.  Roughly 475,000 emergency room visits each year are attributable
			 to the misuse and abuse of opioid pain medication.</text>
      </paragraph>
      <paragraph id="id53b1cea0517f429598c00e12fea8d62d">
        <enum>(5)</enum>
        <text>Effective medication-assisted treatment for opioid addiction can decrease overdose deaths, be
			 cost-effective, reduce transmissions of HIV and viral hepatitis, and
			 reduce other social harms such as criminal
			 activity.</text>
      </paragraph>
      <paragraph id="id3006bfee5f174b819c918397432165be">
        <enum>(6)</enum>
        <text>Effective medication-assisted treatment programs for opioid addiction should include multiple
			 components, including medications, cognitive and behavioral supports and
			 interventions, and
			 drug testing.</text>
      </paragraph>
      <paragraph id="idA97B94154B6F4E3390EEB58346BC2BD8">
        <enum>(7)</enum>
        <text>Effective medication-assisted treatment programs for opioid addiction may use a team of staff
			 members, in addition to a prescribing provider, to deliver comprehensive
			 care.</text>
      </paragraph>
      <paragraph id="id8c02762f803249a39961a68810001932">
        <enum>(8)</enum>
        <text>Access to medication-assisted treatments, including office-based buprenorphine opioid treatment,
			 remains limited in part due to current practice regulations and an
			 insufficient number of providers.</text>
      </paragraph>
      <paragraph id="id0cdfa82d928448d79cb8fe20158f5a35">
        <enum>(9)</enum>
        <text>More than 10 years of experience in the United States with office-based buprenorphine opioid
			 treatment has informed best practices for delivering successful, high
			 quality care.</text>
      </paragraph>
    </section>
    <section id="id3d123a5bab544c7fb641214ed34e3590">
      <enum>3.</enum>
      <header>Expansion of patient limits under waiver</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:B">Section 303(g)(2)(B) of the Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/823/g/2/B">21 U.S.C.  823(g)(2)(B)</cato:entity-ref>)</cato:entity>  is amended—</text>
      <paragraph id="idcbb4920bd9b948598e70ccce5f89b518">
        <enum>(1)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:i">clause (i)</cato:entity-ref>, by striking <term>physician</term> and inserting <term>practitioner</term>;</text>
      </paragraph>
      <paragraph id="id3c8bd7de8bf74016a0fd1e6ba6468cd9">
        <enum>(2)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:iii">clause (iii)</cato:entity-ref>—</text>
        <subparagraph id="idFD1661D7D73143B6B6DD94F6DCE3E44E">
          <enum>(A)</enum>
          <text>by striking <quote>30</quote> and inserting <quote>100</quote>;  and</text>
        </subparagraph>
        <subparagraph id="id7BC48357C70847788D087CB1DC4CA5F8">
          <enum>(B)</enum>
          <text>by striking <quote>, unless, not sooner</quote> and all that follows through the end and inserting a period; and</text>
        </subparagraph>
      </paragraph>
      <paragraph id="id26448ce924134d678990b32842b79fcd">
        <enum>(3)</enum>
        <text>by inserting at the end the following new clause:</text>
        <quoted-block display-inline="no-display-inline" id="id8ca14fc5c97f467487db76e3318e05c7" style="OLC">
          <clause id="id6592a3e7d7fb49c1bfb20f56d6c31d16" indent="up1">
            <enum>(iv)</enum>
            <text>Not earlier than 1 year after the date on which a qualifying practitioner obtained an initial
			 waiver
			 pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:iii">clause (iii)</cato:entity-ref>, the qualifying practitioner may submit a second
			 notification to
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> of the need and intent of the qualifying practitioner to
			 treat an unlimited number of patients, if the qualifying
			 practitioner—</text>
            <subclause id="id83ffb943d4be4437891911c30f7b5766">
              <enum>(I)</enum>
              <item commented="no" display-inline="yes-display-inline" id="id5CB857F2EDF346F49903F666E7A2F386">
                <enum>(aa)</enum>
                <text>satisfies the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:aa" proposed="true">item (aa)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:bb" proposed="true">(bb)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:cc" proposed="true">(cc)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:dd" proposed="true">(dd) of subparagraph (G)(ii)(I)</cato:entity-ref>; and</text>
              </item>
              <item id="idf3285b936318497996280629933197df" indent="up1">
                <enum>(bb)</enum>
                <text>agrees to fully participate in the Prescription Drug Monitoring Program of the State in which the
			 qualifying practitioner is licensed, pursuant to
			 applicable State guidelines; or</text>
              </item>
            </subclause>
            <subclause id="id14ec281f95144bc89c0ee46ebb92d50b">
              <enum>(II)</enum>
              <item commented="no" display-inline="yes-display-inline" id="id170D7A1D0A2345678B33D35AFF957F03">
                <enum>(aa)</enum>
                <text>satisfies the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:ee" proposed="true">item (ee)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:ff" proposed="true">(ff)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:gg" proposed="true">(gg) of subparagraph (G)(ii)(I)</cato:entity-ref>;</text>
              </item>
              <item id="id2729603758f742c49f62af886a3070cc" indent="up1">
                <enum>(bb)</enum>
                <text>agrees to fully participate in the Prescription Drug Monitoring Program of the State in which the
			 qualifying practitioner is licensed, pursuant to
			 applicable State guidelines;</text>
              </item>
              <item id="id583b4ab5361745cf89f10e3fd31ec141" indent="up1">
                <enum>(cc)</enum>
                <text>practices in a qualified practice setting; and</text>
              </item>
              <item id="id44FD06DB3ED6472282ADE68C65859397" indent="up1">
                <enum>(dd)</enum>
                <text>has completed not less than 24 hours of training (through classroom situations, seminars at
			 professional society meetings, electronic communications, or otherwise)
			 with respect to the treatment and management of opiate-dependent patients
			  for substance use disorders provided by the American Society of Addiction
			 Medicine, the American
			 Academy of Addiction Psychiatry, the American Medical Association, the
			 American Osteopathic Association, the American Psychiatric Association, or
			 any other organization that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines is appropriate for
			 purposes of this subclause.</text>
              </item>
            </subclause>
          </clause>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </paragraph>
    </section>
    <section id="id48764625c37a4611942372465a1d45a9">
      <enum>4.</enum>
      <header>Definitions</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G">Section 303(g)(2)(G) of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/823">
          <cato:entity-ref entity-type="uscode" value="usc/21/823/g/2/G">21 U.S.C. 823(g)(2)(G)</cato:entity-ref>
        </external-xref>)</cato:entity> is amended—</text>
      <paragraph id="id5333DFFCFC174F43A1EDBDB7D012B6F1">
        <enum>(1)</enum>
        <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii">clause (ii)</cato:entity-ref> and inserting the following:</text>
        <quoted-block display-inline="no-display-inline" id="id9F77D4FC3C1A4D4DB937712DD479E576" style="OLC">
          <clause id="idca301b394f5e4002976257ac78ba4fc9" indent="up1">
            <enum>(ii)</enum>
            <text>The term <term>qualifying practitioner</term> means the following:</text>
            <subclause id="id7343ee8db9434ee7bf067065f65a21ce">
              <enum>(I)</enum>
              <text>A physician who is licensed under State law and who meets 1 or more of the following conditions:</text>
              <item id="idaeb6c7b58d7d4dd184d807a49e8ad335">
                <enum>(aa)</enum>
                <text>The physician holds a board certification in addiction psychiatry from the American
			 Board of Medical Specialties.</text>
              </item>
              <item id="id83840ebe7fbe415b8026d75619cc961c">
                <enum>(bb)</enum>
                <text>The physician holds an addiction certification from the American Society of Addiction Medicine.</text>
              </item>
              <item id="id5229649fac634ed6bc43df8fe13bbb0f">
                <enum>(cc)</enum>
                <text>The physician holds a board certification in addiction medicine from the American
			 Osteopathic Association.</text>
              </item>
              <item id="id4a408f3b6d4548a9a70ecd25c53e1ddd">
                <enum>(dd)</enum>
                <text>The physician holds a board certification from the American Board of Addiction
			 Medicine.</text>
              </item>
              <item id="ida3f59fa9fd2e4b63a0fc7f702def88c4">
                <enum>(ee)</enum>
                <text>The physician has completed not less than 8 hours of training (through classroom situations,
			 seminar at professional society meetings, electronic communications, or
			 otherwise) with respect to the treatment and management of
			 opiate-dependent patients for substance use disorders provided by the
			 American Society of Addiction
			 Medicine, the American Academy of Addiction Psychiatry, the American
			 Medical Association, the American Osteopathic Association, the American
			 Psychiatric Association, or any other organization that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
			 determines is appropriate for purposes of this subclause.</text>
              </item>
              <item id="id742a9e6274b448879cc18b5749f387e6">
                <enum>(ff)</enum>
                <text>The physician has participated as an investigator in 1 or more clinical trials leading to the
			 approval of a narcotic drug in schedule III, IV, or V for maintenance or
			 detoxification treatment, as demonstrated by a statement submitted to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> by this sponsor of such approved drug.</text>
              </item>
              <item id="idda0b59fdbc734051bf6a91ad06c14100">
                <enum>(gg)</enum>
                <text>The physician has such other training or experience as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines will demonstrate
			 the ability of the physician to treat and manage opiate-dependent
			 patients.</text>
              </item>
            </subclause>
            <subclause id="idf3e6653dd2a444308c0b3f441011125e">
              <enum>(II)</enum>
              <text>A nurse practitioner or physician assistant who is licensed under State law and meets all of the
			 following conditions:</text>
              <item id="id4a2a432bce1f4c1e9a369d6c1cb9dd33">
                <enum>(aa)</enum>
                <text>The nurse practitioner or physician assistant is licensed under State law to prescribe schedule
			 III, IV, or V medications for pain.</text>
              </item>
              <item id="ide839ef0cfcb247a9aab5a8045bfba826">
                <enum>(bb)</enum>
                <text>The nurse practitioner or physician assistant satisfies 1 or more of the following:</text>
                <subitem id="id2af3bfacd8664c30819bf11665605b3c">
                  <enum>(AA)</enum>
                  <text>Has completed not fewer than 24 hours of training (through classroom situations, seminar at
			 professional society meetings, electronic communications, or otherwise) 
			 with respect to the treatment and management of opiate-dependent patients
			 for substance use disorders provided by the American Society of Addiction
			 Medicine, the American
			 Academy of Addiction Psychiatry, the American Medical Association, the
			 American Osteopathic Association, the American Psychiatric Association, or
			 any other organization that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines is appropriate for
			 purposes of this subclause.</text>
                </subitem>
                <subitem id="id801c88d287c7446da023ddab36bc32ff">
                  <enum>(BB)</enum>
                  <text>Has such other training or experience as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines will demonstrate the ability of
			 the nurse practitioner or physician assistant to treat and manage
			 opiate-dependent patients.</text>
                </subitem>
              </item>
              <item id="idd6d75299f75a444385e13cec585339a0">
                <enum>(cc)</enum>
                <text>The nurse practitioner or physician assistant practices under the supervision of a licensed
			 physician who holds an active waiver to prescribe schedule III, IV, or V
			 narcotic medications for opioid addiction therapy, and—</text>
                <subitem id="idd17eaae068cb4315b6be83a6dc4a7dce">
                  <enum>(AA)</enum>
                  <text>the supervising physician satisfies the conditions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:aa" proposed="true">item (aa)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:bb" proposed="true">(bb)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:cc" proposed="true">(cc)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:dd" proposed="true">(dd) of subclause
			 (I)</cato:entity-ref>; or</text>
                </subitem>
                <subitem id="id09a7def18fea4de3822e6f18b828c8fa">
                  <enum>(BB)</enum>
                  <text>both the supervising physician and the nurse practitioner or physician assistant practice in a
			 qualified practice setting.</text>
                </subitem>
              </item>
            </subclause>
            <subclause id="id69e1b8a1086e49a5b83e93808c75bcee">
              <enum>(III)</enum>
              <text>A nurse practitioner who is licensed under State law and meets all of the following conditions:</text>
              <item id="idaac3982466c74f6ab4e5d6c6dfdb4119">
                <enum>(aa)</enum>
                <text>The nurse practitioner is licensed under State law to prescribe schedule III, IV, or V medications
			 for pain.</text>
              </item>
              <item id="id23e7976183d045b092ca81fb4493e13d">
                <enum>(bb)</enum>
                <text>The nurse practitioner has training or experience that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines demonstrates
			 specialization in the ability to treat opiate-dependent patients, such as
			 a certification in addiction specialty accredited by the American Board
			 of Nursing Specialties or the National Commission for Certifying
			 Agencies,  or a certification in addiction nursing as a Certified
			 Addiction Registered Nurse—Advanced Practice.</text>
              </item>
              <item id="ide668e06648184a1f90b67db7ac1b61bb">
                <enum>(cc)</enum>
                <text>In accordance with State law, the nurse practitioner prescribes opioid addiction therapy in
			 collaboration with a physician  who holds an active waiver to prescribe
			 schedule III, IV, or V narcotic medications for opioid addiction therapy.</text>
              </item>
              <item id="id66e4007f038d412b979d911784caa19e">
                <enum>(dd)</enum>
                <text>The nurse practitioner practices in a qualified practice setting.</text>
              </item>
            </subclause>
          </clause>
          <after-quoted-block>; and</after-quoted-block>
        </quoted-block>
      </paragraph>
      <paragraph id="id1df1998b07824ee1b1477886cfb1ce3d">
        <enum>(2)</enum>
        <text>by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="id131824DD20CB4AFAB984CC8044C0D22C" style="OLC">
          <clause id="ide0ddee510edd41f3b566ae42eae343ca" indent="up1">
            <enum>(iii)</enum>
            <text>The term <term>qualified practice setting</term> means 1 or more of the following treatment settings:</text>
            <subclause id="id8e922219552843c38489ac4a99cc84be">
              <enum>(I)</enum>
              <text>A National Committee for Quality Assurance-recognized Patient-Centered Medical Home or
			 Patient-Centered Specialty Practice.</text>
            </subclause>
            <subclause id="id70bdc5df4dfe428fa6f3235c45ddcc35">
              <enum>(II)</enum>
              <text>A <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7530" entity-type="federal-body">Centers for Medicaid &amp; Medicare Services</cato:entity-ref>-recognized Accountable Care Organization.</text>
            </subclause>
            <subclause id="id1be92665fcd844b5a3154ca3dc52a1fb">
              <enum>(III)</enum>
              <text>A clinical facility administered by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="3600" entity-type="federal-body">Department of Veterans Affairs</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="9700" entity-type="federal-body">Department of Defense</cato:entity-ref>, or
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7527" entity-type="federal-body">Indian Health Service</cato:entity-ref>.</text>
            </subclause>
            <subclause id="idC21A44D879824EE6A64373E819DC7EF9">
              <enum>(IV)</enum>
              <text>A Behavioral Health Home accredited by the Joint Commission.</text>
            </subclause>
            <subclause id="id596cec151a65401ba1ef50e3a92e406d">
              <enum>(V)</enum>
              <text>A Federally-qualified health center (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref entity-type="act" value="Social Security Act/s:1905/ss:l/p:2/sp:B">section 1905(l)(2)(B) of the Social Security Act</cato:entity-ref>
			 (<external-xref legal-doc="usc" parsable-cite="usc/42/1396d">
                  <cato:entity-ref entity-type="uscode" value="usc/42/1396d/l/2/B">42 U.S.C. 1396d(l)(2)(B)</cato:entity-ref>
                </external-xref>)</cato:entity>) or
			 a Federally-qualified health center look-alike.</text>
            </subclause>
            <subclause id="id4144c5708c98441f988b650986dbc7cf">
              <enum>(VI)</enum>
              <text>A Substance Abuse and Mental Health Services-certified Opioid Treatment Program.</text>
            </subclause>
            <subclause id="idf66615e3f6414ba3881378101e568e71">
              <enum>(VII)</enum>
              <text>A clinical program of a  State or Federal jail, prison, or other facility where individuals are
			 incarcerated.</text>
            </subclause>
            <subclause id="idc83f5fe03d4545c1a8aabef9211e5ff5">
              <enum>(VIII)</enum>
              <text>A clinic that demonstrates compliance with the Model Policy on
			 DATA 2000 and Treatment of Opioid Addiction in the Medical Office issued
			 by the Federation of State Medical Boards.</text>
            </subclause>
            <subclause id="id6e5104c9f20849dcab42c7cf832d6956">
              <enum>(IX)</enum>
              <text>A treatment setting that is part of an Accreditation Council for Graduate Medical Education,
			 American
			 Association of Colleges of Osteopathic Medicine, or American
			 Osteopathic Association-accredited residency or fellowship training
			 program.</text>
            </subclause>
            <subclause id="id9b41d686fbd945a98cc76f84953935ce">
              <enum>(X)</enum>
              <text>Any other practice setting approved by a State regulatory board or State Medicaid Plan to provide
			 addiction treatment services.</text>
            </subclause>
            <subclause id="idecf8e30390a44624b4666448931c1b6b">
              <enum>(XI)</enum>
              <text>Any other practice setting approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body">Secretary</cato:entity-ref>.</text>
            </subclause>
          </clause>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </paragraph>
    </section>
    <section id="id6CEB1E7954C6400B99164C31C1D6A2D7">
      <enum>5.</enum>
      <header>GAO Evaluation</header>
      <text display-inline="no-display-inline">Two years after the date on which the first notification under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:iv" proposed="true">clause (iv) of section
			 303(g)(2)(B) of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/823">
          <cato:entity-ref entity-type="uscode" value="usc/21/823/g/2/B">21 U.S.C. 823(g)(2)(B)</cato:entity-ref>
        </external-xref>)</cato:entity>, as
			 added by this Act,  is received by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human
			 Services</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller General of the United States</cato:entity-ref> shall initiate an
			 evaluation of the
			 effectiveness of the  amendments made by this Act, which shall include an
			 evaluation of—</text>
      <paragraph id="id33BA2A803D8B4F19998B293D125BF0E5">
        <enum>(1)</enum>
        <text>any changes in the availability and use of medication-assisted treatment for opioid addiction;</text>
      </paragraph>
      <paragraph id="id29A0097F24134C1CA660F6B9DB4DFED1">
        <enum>(2)</enum>
        <text>the quality of medication-assisted treatment programs;</text>
      </paragraph>
      <paragraph id="idEAFA93BC7CC5449D89F6FE2D10DB351C">
        <enum>(3)</enum>
        <text>the integration of medication-assisted treatment with routine healthcare services;</text>
      </paragraph>
      <paragraph id="id1FD57B2D785E41E3922159EBE33738D1">
        <enum>(4)</enum>
        <text>diversion of opioid addiction treatment medication;</text>
      </paragraph>
      <paragraph id="id91B3E29699E244CF9A767D53B080FE7E">
        <enum>(5)</enum>
        <text>changes in State or local policies and legislation relating to opioid addiction treatment;</text>
      </paragraph>
      <paragraph id="id2E686C8573E2481F907C5A9F0DB05929">
        <enum>(6)</enum>
        <text>the use of nurse practitioners and physician assistants who prescribe opioid addiction medication;</text>
      </paragraph>
      <paragraph id="id2a8b5709bfa84e9389e44b0cd1becbf9">
        <enum>(7)</enum>
        <text>the use of Prescription Drug Monitoring Programs by waived practitioners to maximize safety of
			 patient care and prevent diversion of opioid addiction medication;</text>
      </paragraph>
      <paragraph id="id2f09752bf92c474bab4baec5682fafc2">
        <enum>(8)</enum>
        <text>the findings of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement Agency</cato:entity-ref> inspections of waived practitioners, including the
			 frequency with which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement Agency</cato:entity-ref> finds no
			 documentation of access to behavioral health services; and</text>
      </paragraph>
      <paragraph id="id2551f05351554cc2a0742a3f2c729915">
        <enum>(9)</enum>
        <text>the effectiveness of cross-agency collaboration between <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Department of Health and Human	Services</cato:entity-ref>
			 and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement Agency</cato:entity-ref> for expanding effective opioid addiction
			 treatment.</text>
      </paragraph>
    </section>
  </legis-body>
</bill>
</doc>